Gabriel Schembri
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Estimated glomerular filtration rate slopes on tenofovir alafenamide.
Journal: HIV medicine
Published: May 27, 2020
Detection of the United States Neisseria meningitidis urethritis clade in the United Kingdom, August and December 2019 - emergence of multiple antibiotic resistance calls for vigilance.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: April 23, 2020
Test of cure study: a feasibility study to estimate the time to test of cure (TOC) for Neisseria gonorrhoeae and Chlamydia trachomatis infections.
Journal: Sexually transmitted infections
Published: October 01, 2019
The Context of Sexual Risk Behaviour Among Men Who Have Sex with Men Seeking PrEP, and the Impact of PrEP on Sexual Behaviour.
Journal: AIDS and behavior
Published: October 12, 2018
Sexual behaviours and sexually transmitted infection outcomes in a cohort of HIV-negative men who have sex with men attending sexual health clinics in England.
Journal: International journal of STD & AIDS
Published: August 18, 2018
Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial.
Journal: HIV clinical trials
Published: March 18, 2017
Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study.
Journal: PloS one
Published: January 06, 2017
Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial).
Journal: The Journal of antimicrobial chemotherapy
Published: November 15, 2016
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
Journal: Lancet (London, England)
Published: September 14, 2015
Should we screen heterosexuals for extra-genital chlamydial and gonococcal infections?
Journal: International journal of STD & AIDS
Published: February 02, 2014
Last Updated: 09/26/2026